These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5034400)

  • 21. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 22. [A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action (author's transl)].
    Ledoux F; Welsch M; Steimer C; Schwartz J
    Therapie; 1981; 36(2):187-91. PubMed ID: 7027519
    [No Abstract]   [Full Text] [Related]  

  • 23. [Envacar and envacar and renese in 8 cases of arterial hypertension in children].
    Halikowski B; Kucharska K; Rybakowa M
    Pediatr Pol; 1968 Apr; 43(4):441-6. PubMed ID: 4877358
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical trial of a new antihypertensive drug: guanoxan].
    Linquette M; Fossati P; May JP
    Lille Med; 1968; 13(6):Suppl 720-2. PubMed ID: 5684063
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical study and evaluation of a new guanidine derivative: "Ciclazenine" in the therapy of arterial hypertension].
    Del Guercio R; Valva M; Conti G; Savarese A; Piemontese M
    Rass Int Clin Ter; 1969 May; 49(10):591-604. PubMed ID: 5784806
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new drug in the medical treatment of arterial hypertension: cyclazenin].
    Mameli P; Maioli M; Fanzecu P
    Rass Int Clin Ter; 1970 Apr; 50(8):457-64. PubMed ID: 4394494
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with a new antihypertensive agent (Tadip)].
    Becker L
    Med Welt; 1968 Jul; 30():1684-5. PubMed ID: 5718817
    [No Abstract]   [Full Text] [Related]  

  • 28. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical assessment of the new antihypertensive Compound--1029 (Vatensol)--Guanoclor.
    Mehta AB; Biswas AK; Pinto IJ; Sheth UK
    Indian Heart J; 1967 Oct; 19(4):322-8. PubMed ID: 4870898
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experiences with drenusil-R in general practice].
    Schnorrenberg G
    Z Allgemeinmed; 1970 Jun; 46(18):937-9. PubMed ID: 5509313
    [No Abstract]   [Full Text] [Related]  

  • 31. [Guanfacine: controlled clinical study in arterial hypertension].
    Lauro R
    Clin Ter; 1980 May; 93(4):439-55. PubMed ID: 6998644
    [No Abstract]   [Full Text] [Related]  

  • 32. Further observations on a new antihypertensive Vatensol (Compound 1029).
    Srivastava BN; Vyas GP; Tiwari AK; Tapa RS; Nema HS
    Indian Heart J; 1967 Oct; 19(4):329-35. PubMed ID: 4870899
    [No Abstract]   [Full Text] [Related]  

  • 33. Reserpine-frusemide and reserpine-polythiazide combinations in hypertension.
    Mukerjee AB
    J Indian Med Assoc; 1973 Mar; 60(5):168-72. PubMed ID: 4723077
    [No Abstract]   [Full Text] [Related]  

  • 34. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prazosin hydrochloride (CP-12,299-1), an oral anti-hypertensive agent: preliminary clinical observations in ambulatory patients.
    Cohen BM
    J Clin Pharmacol J New Drugs; 1970; 10(6):408-17. PubMed ID: 4920492
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Controlled clinical trial of a new antihypertensive drug: 2,6-dichlorobenzylidene-amino-guanidine acetate].
    Di Veroli C; Petrucci D
    Clin Ter; 1976 Feb; 76(4-3):333-40. PubMed ID: 786534
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ciclazenine in the therapy of arterial hypertension].
    Busilacchi M; Perpignano G; Altieri P; Verzetti G
    Rass Int Clin Ter; 1969 May; 49(10):605-14. PubMed ID: 5784807
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experiences with Envacar for hypertensives].
    Internist Prax; 1965; 5(3):489-90. PubMed ID: 5830703
    [No Abstract]   [Full Text] [Related]  

  • 40. [Guancydine. Clinical evaluation of a new hypotensive agent].
    da Silva JA; Antunes NM; Laraia Cde B; Fraga Filho C
    Rev Bras Med; 1972 Jan; 29(1):42-7. PubMed ID: 5017517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.